Fujisawa, Japan

Toru Yamashita

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toru Yamashita. Retrieved from https://idiyas.com/inventor/toru-yamashita-u2a15onp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 19.3

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Toru Yamashita

Introduction

Toru Yamashita is a notable inventor based in Fujisawa-shi, Kanagawa, Japan. He is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Despite having no patents to his name, his contributions to the field of pharmaceuticals are significant.

Latest Patents

As of now, Toru Yamashita holds 3 patents. This indicates that his work may focus more on research and development rather than patenting inventions.

Career Highlights

Throughout his career, Toru Yamashita has been involved in various projects at Takeda Pharmaceutical Company Limited. His expertise in the pharmaceutical industry has allowed him to contribute to the development of innovative treatments and therapies.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Toru Yamashita's work at Takeda Pharmaceutical Company Limited showcases his dedication to advancing pharmaceutical innovations, even in the absence of patents. His contributions are valuable to the industry and reflect the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…